DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,527,015 | +2.8% | 26,308 | -0.5% | 3.54% | -0.8% |
| Q2 2023 | $6,352,018 | -7.6% | 26,437 | -3.0% | 3.57% | -14.1% |
| Q1 2023 | $6,876,488 | +91611.0% | 27,254 | -3.4% | 4.15% | -11.5% |
| Q4 2022 | $7,498 | -99.9% | 28,222 | -2.5% | 4.69% | -2.4% |
| Q3 2022 | $7,480,000 | -50.4% | 28,931 | -51.3% | 4.80% | +7.0% |
| Q2 2022 | $15,080,000 | +881.8% | 59,424 | +106.6% | 4.49% | +503.4% |
| Q1 2022 | $1,536,000 | -85.2% | 28,766 | -8.8% | 0.74% | -84.6% |
| Q4 2021 | $10,381,000 | +4.1% | 31,533 | -3.7% | 4.82% | -1.2% |
| Q3 2021 | $9,976,000 | +12.3% | 32,746 | -1.0% | 4.88% | +10.7% |
| Q2 2021 | $8,884,000 | +13.4% | 33,078 | -4.9% | 4.41% | +5.3% |
| Q1 2021 | $7,837,000 | -0.7% | 34,785 | -2.0% | 4.19% | -5.5% |
| Q4 2020 | $7,893,000 | +2.0% | 35,505 | -1.1% | 4.43% | -14.5% |
| Q3 2020 | $7,737,000 | +21.5% | 35,903 | -0.2% | 5.19% | +6.9% |
| Q2 2020 | $6,369,000 | +27.4% | 35,981 | -0.2% | 4.85% | +0.4% |
| Q1 2020 | $4,998,000 | -12.0% | 36,065 | -2.4% | 4.83% | +24.6% |
| Q4 2019 | $5,677,000 | -5.1% | 36,945 | -10.7% | 3.88% | -11.5% |
| Q3 2019 | $5,981,000 | -30.6% | 41,362 | -31.4% | 4.38% | -11.7% |
| Q2 2019 | $8,623,000 | +6.4% | 60,262 | -1.7% | 4.96% | +4.2% |
| Q1 2019 | $8,108,000 | +27.4% | 61,333 | -0.3% | 4.76% | +13.2% |
| Q4 2018 | $6,364,000 | -6.8% | 61,523 | -2.0% | 4.21% | +8.9% |
| Q3 2018 | $6,831,000 | +6.2% | 62,776 | -3.5% | 3.86% | -8.6% |
| Q2 2018 | $6,432,000 | -2.9% | 65,071 | -3.6% | 4.23% | +0.6% |
| Q1 2018 | $6,623,000 | +3.2% | 67,534 | -2.2% | 4.20% | +18.5% |
| Q4 2017 | $6,418,000 | +7.3% | 69,037 | -0.8% | 3.55% | +0.8% |
| Q3 2017 | $5,979,000 | +1.2% | 69,593 | -0.4% | 3.52% | -5.9% |
| Q2 2017 | $5,907,000 | -1.7% | 69,881 | -0.3% | 3.74% | -7.3% |
| Q1 2017 | $6,007,000 | +3.8% | 70,115 | -5.5% | 4.04% | -2.0% |
| Q4 2016 | $5,786,000 | +1.1% | 74,210 | +1.8% | 4.12% | -3.5% |
| Q3 2016 | $5,721,000 | -24.7% | 72,870 | -2.9% | 4.27% | -20.8% |
| Q2 2016 | $7,595,000 | +3.1% | 75,080 | -3.0% | 5.39% | +0.7% |
| Q1 2016 | $7,366,000 | +1.5% | 77,390 | -0.8% | 5.35% | +18.9% |
| Q4 2015 | $7,257,000 | +10.2% | 78,015 | +1.3% | 4.50% | +12.0% |
| Q3 2015 | $6,583,000 | -4.7% | 77,014 | -4.4% | 4.02% | -5.4% |
| Q2 2015 | $6,906,000 | -0.4% | 80,562 | -1.2% | 4.24% | -5.7% |
| Q1 2015 | $6,934,000 | -7.5% | 81,545 | -6.7% | 4.50% | -6.8% |
| Q4 2014 | $7,496,000 | +18.4% | 87,355 | +5.0% | 4.83% | +13.8% |
| Q3 2014 | $6,332,000 | -3.6% | 83,228 | -0.1% | 4.24% | +15.7% |
| Q2 2014 | $6,566,000 | -0.5% | 83,298 | -5.2% | 3.66% | -7.4% |
| Q1 2014 | $6,598,000 | -2.6% | 87,858 | +0.2% | 3.96% | -14.5% |
| Q4 2013 | $6,772,000 | +9.5% | 87,698 | -1.7% | 4.63% | -3.3% |
| Q3 2013 | $6,183,000 | +16.1% | 89,193 | +6.0% | 4.79% | -11.2% |
| Q2 2013 | $5,325,000 | – | 84,128 | – | 5.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |